2h
Stockhead on MSNHealth Check: Emvision’s stroke detector takes to the skiesRoyal Flying Doctor Service paramedics have successfully tested Emvision's portable stroke detector, First Responder. ...
The Food and Drug Administration (FDA) on Tuesday announced a new initiative titled “Operation Stork Speed” aimed at ...
The announcement comes as Kennedy has long touted the effectiveness of a healthy diet mitigating disease in humans.
INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...
8h
Everyday Health on MSNRFK Jr. Asks Food Companies to Stop Using Artificial DyesThe U.S. Health and Human Services Secretary is pushing to end a rule that allows food companies to use additives that ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...
Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.
One practice now under greater scrutiny is health care insurers’ use of artificial intelligence (AI) algorithms to deny ...
Proposals to eliminate the self-affirmed GRAS pathway have sent shockwaves through the food industry. But what do they mean ...
Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...
The Health and Human Services Secretary directed the FDA to consider eliminating a pathway that allowed companies to ...
Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results